Genesis Electronics Group, Inc (OTC: GEGI) via its wholly owned subsidiary Glid, is in the process of constructing cutting-edge autonomous road-to-rail shipping vehicles known as Gliders. These innovative vehicles will facilitate the transportation of fully loaded semi-trailers onto railway tracks, even in scenarios where it was previously deemed impractical. Genesis Electronics Group intends to possess and operate every Glider within its fleet, while also offering a business model referred to as "Glider-as-a-Service."

On May 4, 2023, Genesis Electronics Group, Inc. made an announcement regarding the completion of its current Reg A offering with the final subscription agreement for $190,000 from Strategic Investor, 40 Brightwater, LLC. As per Rule 144, these shares will be subject to restrictions due to the size of the investment.

Kevin Damoa, the CEO of Genesis Electronics Group, expressed appreciation for Shannon Newby and 40 Brightwater LLC's investment, emphasizing its significance for both their Glid technology and the nation's commitment to swiftly transitioning towards a greener and more sustainable future. The company is grateful for the belief and support received and eagerly anticipates collaborating to forge a brighter tomorrow in intermodal transportation.

Also, on May 26, 2023, Genesis Electronics Group, Inc. (GEGI) announced the execution of loan agreements for a credit facility with 40 Brightwater, LLC, allowing GEGI to borrow up to $750,000. The loan is expected to be finalized and funded by June 15, 2023.

Following their initial investment in GEGI through the Company's Reg A offering, 40 Brightwater, LLC has demonstrated growing interest in GEGI's business, technology, management team, and business potential. They are now providing this credit facility to support GEGI's operations and the development of its initial Glider units.

The proposed loan is part of a larger financial arrangement between Clear Rock Sustainable Energy, Inc. (Clear Rock Energy) and 40 Brightwater, LLC. This arrangement aims to establish an expanded business relationship between Genesis Electronics Group and Clear Rock Energy, focusing on GEGI's Glid autonomous road-to-rail patent-pending shipping technology. The collaboration seeks to explore new business opportunities in Mexico, Nigeria, South Africa, and Zimbabwe, where Clear Rock Energy has subsidiaries and business relationships. The ultimate goal is to secure new global markets for Genesis Electronics Group's Gliders.

Since then, the stock has experienced a 150% and chatters seems to be picking more and more each day. So far today, the stock is up 30% on 43m shares traded and doesnt look to be slowing down just yet. Keep an eye on this one for potentially more updates to come in June.

AAP, Inc. (OTC: AAPJ) is a holding company and focuses its efforts on acquisition of suitable projects. 

On Jan. 24, 2023, AAP, Inc., announced the cancellations of agreements with Redtail LLC. for $1.5 million and in house debt collections for $550,000. The company stated it will eliminate a lot of overhangs on the company, providing them with more focus and control over their interest in the Buddha Company, a Los Angeles based cannabis business. 

On May 2, 2023, the company announced that they've acquired $1.6 million in real estate assets to be developed in, Makati, Metro Manila, Philippines. Paul Bakajin, the CEO, stated: "We are very excited about this opportunity for the future of the company and its shareholders. We anticipate acquiring substantially more assets in and around Metro Manila in the near future. We are 100% in control of these real estate assets, providing us with more control over the information dissemination process and allowing us to provide more news releases and updates for our shareholders. This is something we were unable to adequately do with prior business associations. We look forward to building an exciting future in real estate asset development in a dynamic emerging market like the Philippines where we can leverage the company in so many different ways, monetarily and functionally, ensuring a sound investment for us for the long-term." 

After hitting lows of .0010 last week, the stock has now reversed and is touching highs of .0032 with 3.4m shares traded for the day so far. The stock is currently up 20% today and has continued to increase in chatter. We previously mentioned this one last tuesday and so far has experienced a great move, but continue to keep this one on watch for potential updates soon.

CNBX Pharmaceuticals Inc. (OTC: CNBX) is an advanced-stage biopharmaceutical company that specializes in the exploration, advancement, and commercialization of groundbreaking products and innovative technologies harnessing the potential of cannabinoids for treating cancer. By combining their exclusive technologies with the expertise of esteemed scientists, they strive to unlock the medicinal properties of cannabis and its diverse array of bioactive components. Through extensive testing on biopsies and cell lines, they have conducted numerous studies to understand how cannabinoids influence the cell cycle and cell death processes. At the heart of their operations lies a dynamic bioinformatics platform that continuously evolves, leveraging high throughput screening technology, advanced data analytics, artificial intelligence, and proprietary methodologies. This enables them to swiftly analyze the physiological effects of multiple cannabinoid compounds on tumor cells.

Their latest PR back on November 8, 2022, announced their acquisition of a controlling interest in TaGeza Biopharmaceuticals Ltd. Despite the acquisition, the dedicated research team at TaGeza remains fully committed to the company's mission. Prof. Benjamin Dekel (MD, PhD), co-founder of TaGeza, will continue to serve as the Chief Scientist, while Gabriel Yariv, Chairman of CNBX, will assume the role of CEO at TaGeza Biopharmaceuticals.

TaGeza, established in 2014 by a medical team from Sheba Medical Center, the largest hospital in Israel, focuses on developing advanced immunotherapy and cancer-targeted treatments. Currently, the company is working on pioneering Antibody Drug Conjugates (ADCs) based on novel monoclonal antibodies (mAbs) that specifically target Cancer Stem Cells (CSCs) or Tumor Initiating Cells (TICs), a highly tumorigenic subpopulation of cancer cells. By targeting CSCs/TICs, TaGeza aims to improve patient outcomes and reduce the risk of relapse, which often occurs due to the presence of chemotherapy-resistant tumor cells enriched by CSCs or TICs.

ADC therapies have gained significant traction in the global oncological therapeutics market. There are currently 11 Antibody Drug Conjugate therapies approved for marketing worldwide, with six of them receiving clearance in the past three years alone. ADCs are predominantly used in hematology and solid tumor therapy. Market analysis conducted by Nature in August 2021 indicates that several available ADCs generate annual sales exceeding $1 billion, and it is forecasted that the combined annual sales of currently marketed ADCs will exceed $16 billion by 2026.

CNBX's stock is currently experiencing new highs every day with decent volume. A key level to watch for continuation breakout is 0.025. It currently is sitting above that key level and is waiting for an influx of volume to continue higher. Also, this stock can be pretty volatile in either direction so make sure to manage your risk and keep an eye for any updates from the company.

GOLDEN TRIANGLE VENTURES INC. (OTC: GTVH) is a versatile consulting company that actively explores opportunities in the Health, Entertainment, and Technology industries. GTV operates a diverse portfolio of companies and services that synergistically benefit these sectors. The company's primary objective is to acquire, purchase, or enter into joint ventures with established entities operating in these industries. Furthermore, GTV offers professional corporate representation services to various companies within these sectors, providing consultation on a wide range of business development goals. The goods and services provided by GTV are developed by passionate innovators who are deeply committed to these markets. GTV aims to leverage its relationships and establish a platform that empowers both new and existing businesses to enhance the quality and scope of their products and services.

The company has pretty silent and hasn't released any news in some time, but the company just recently posted a tweet on twitter saying "Many exciting things are on the edge of development. We have been reorganizing the entire company and can't wait to break our silence."

Since that tweet, the stock has increased its chatter and has moved from .0009 to .0014 experiencing a 50% move on about 25m shares traded. The stock is currently sitting at .0013 and may be one to watch for potential updates in the near term.

Disclaimer:  All content provided by BigTimePennys Report is for informational purposes only. The information provided should not be considered as a substitute for professional advice, analysis, or guidance. Any investment decisions made based on the information provided are solely at the user's own risk. BigTimePennys Report are not liable for any losses or damages incurred as a result of using this information. BigTimePenny is not operated by a licensed broker, a dealer, or a registered investment adviser. The Securities Litigation Reform Act of 1995 provides safe harbor protection for forward-looking statements made by companies or individuals. It should be noted that any forward-looking statements made by BigTimePennys Report, its authors, are not guarantees of future performance or results. These statements are subject to risks, uncertainties, and assumptions that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. The content provided by BigTimePennys Report does not constitute an endorsement, recommendation, or solicitation to buy, sell, or hold any securities or investment products. BigTimePennys Report, its authors, do not endorse or recommend any specific investment strategies, securities, or companies. It is crucial to conduct thorough research and seek advice from a qualified professional before making any investment decisions. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. The user assumes full responsibility for the use of the information provided by BigTimePennys Report. BigTimePennys Report, its authors, disclaim any liability for any direct, indirect, or consequential damages arising from the use or reliance on the information provided. Users should exercise their own judgment and discretion when interpreting and utilizing the information provided. Please note that the content provided by BigTimePennys Report is based on available information and sources believed to be reliable. However, market conditions and regulations may change over time, and there may be inaccuracies or errors in the information provided. It is recommended to verify the information with current and reliable sources before making any investment decisions. Investing in micro-cap companies is highly speculative and carries an extremely high degree of risk. BigTime Penny is not a fiduciary by virtue of any person's use of or access to this content. 

CONTACT: CONTACT: Bigtimepennystocks.com

Editor: mail@bigtimepennystocks.com

.

(C) 2023 M2 COMMUNICATIONS, source M2 PressWIRE